REFRACTORY
Clinical trials for REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY trials appear
Sign up with your email to follow new studies for REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
"Armored" immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-phase study tests the safety of a special type of immune cell, called an "armored" CAR T-cell, in people with certain blood cancers (like CLL) that have not responded to standard treatments. The cells are made from the patient's own blood and are designed to better att…
Matched conditions: REFRACTORY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:28 UTC
-
Virus injected into brain tumors shows promise for children with cancer
Disease control OngoingThis study tests a single injection of a virus (DNX-2401) directly into brain tumors in children and young adults whose cancer has come back or not responded to treatment. The goal is to see if the virus can shrink tumors and help patients live longer. 39 participants will receiv…
Matched conditions: REFRACTORY
Phase: PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Gentler approach to tough myeloma: lower doses may help frail patients
Disease control OngoingThis study tests a combination of three drugs (isatuximab, pomalidomide, and dexamethasone) at lower-than-standard doses in people with multiple myeloma that has returned or not responded to treatment. The goal is to see if this gentler approach is safe and effective for patients…
Matched conditions: REFRACTORY
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:03 UTC